The B-Raf V600E mutation represents the most frequent oncogenic kinase mutation known and is responsible for increased kinase activity in approximately 7% of all human cancers, establishing B-Raf as an important therapeutic target for inhibition.
Other forms of parkinsonism are the consequence of dominant or recessive mutations in specific genes, e.g. α-synuclein, parkin and, more recently, leucine-rich repeat kinase 2 (LRRK2), whose G2019S mutation represents the most prevalent form of late-onset, autosomal dominant familial PD.
IDH1 R132H mutation represents the most common IDH mutation (approximately 90%).
This new mutation represents the most frequent cause of SCA so far in Galicia.
The p.I107T mutation represents the second naturally occurring mutation in the 12-amino-acid-loop of the third GCAP1 EF hand.
Despite these limitations, we believe that the 249ser TP53 mutation represents the best biomarker currently available to assess the biological effect of cumulative aflatoxin exposure.
Whereas the JAK2Val617F acquired mutation represents the first reliable molecular marker of Ph- MPN, it might not be the first genetic event and the molecular causes of the clonal myeloproliferation in PMF patients are still enigmatic.
Clusters of cells displaying strong p53 immunoreactivity can also be infrequently observed in some morphologically normal endometrial glands, suggesting that TP53 mutation represents the earliest step of serous AdCa formation (Jarboe et al, 2009; Zhang et al, 2009).
These values were multiplied by the colony-size ratio of sck2 relative to ade6 mutations, representing the fitness of the query.
